Abiomed
ABMD
Delayed Nasdaq - 11/16 10:00:00 pm
319.78USD
-0.31%
Prev.320.7800
Open318.0400
High332.1500
Low315.3827
Volume752 891
Financials
Sales 2019 773 M
EBIT 2019 224 M
R. net 2019 229 M
Tréso. 2019 484 M
Rend. 2019 -
P/E ratio 2019 64,15
P/E ratio 2020 65,54
EV / Sales 2019 18,0x
EV / Sales 2020 13,8x
Capitalization 14 403 M
Company
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart.

It distributes its products under the Impella brand.

The company was founded in 1981 and is headquartered in Danvers, MA.
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2019-01-31 Earnings Release
Trading Rating :
Investor Rating :
Latest news
11/13ABIOMED : FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior to Reperfusion in Heart Attack Patients is Safe and Feasible
AQ
11/11ABIOMED : FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior to Reperfusion in Heart Attack Patients is Safe and Feasible
BU
11/09ABIOMED : Change in Directors or Principal Officers (form 8-K/A)
AQ
11/06ABIOMED INC : Change in Directors or Principal Officers (form 8-K)
AQ
11/06ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
11/06Two years in, Trump holds stock market bragging rights
RE
11/05ABIOMED : to Present at the Stephens 2018 Investment Conference in New York, NY
AQ
11/02ABIOMED : to Present at the Stephens 2018 Investment Conference in New York, NY
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBullish
Resistance368368450
Spread/Res.-13%-13%-29%
Spread/Supp.2,3%2,3%8,6%
Support313313295